Samyadev Datta, MD
Pain Medicine · Hackensack, NJNPI 1497778005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,242 of the $8,508 with a category attached, or 61.6%. 28 manufacturers reported payments, led by Vertos Medical, Inc. at 35.7% of the total. Reporting peaked in 2022 at $3,026 and has fallen 75.5% since, to $742 in 2025.
Across 260 payments — averaging $32.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$3K
- Vertiflex, Inc.$1K
- Abbott$709
- Boston Scientific$636
- Medtronic$593
- Collegium Pharmaceutical, Inc.$493
- plus $2K from 22 others
Across 49 payments — averaging $1160.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertos Medical, Inc.$54K
- Stryker$3K
What the payments were for
- Consulting fees$2,50029%
- Travel & lodging$7669%
- Food & beverage$5,24262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 24 | $3,036 |
| Vertiflex, Inc. | 7 | $1,068 |
| Abbott | 48 | $709 |
| Boston Scientific | 20 | $636 |
| Medtronic(2 entities) | 11 | $593 |
| Collegium Pharmaceutical, Inc. | 36 | $493 |
| SPR Therapeutics, Inc | 3 | $325 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $289 |
| Relievant Medsystems, Inc. | 8 | $257 |
| Sentynl Therapeutics, Inc. | 20 | $254 |
| Pfizer | 20 | $199 |
| Biodelivery Sciences International, Inc. | 9 | $127 |
| Almatica Pharma LLC | 6 | $85 |
| Arbor Pharmaceuticals, Inc. | 4 | $61 |
| AstraZeneca | 4 | $60 |
| Averitas Pharma Inc. | 3 | $50 |
| Daiichi Sankyo Inc. | 3 | $43 |
| Valinor Pharma, LLC | 2 | $36 |
| Protega Pharmaceutials Inc | 2 | $34 |
| Virtus Pharmaceuticals LLC | 2 | $25 |
| Tersera Therapeutics LLC | 1 | $20 |
| Nevro Corp. | 1 | $19 |
| Merit Medical Systems Inc | 1 | $16 |
| Vertex | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$2,630
- Superion ISS$893
- SPRINT PNS System$180
- INTELLIS ADAPTIVESTIM$164
- PROCLAIM$146
- INTELLIS$145
How this compares
$8,508 in reported general payments places this provider in the 85th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 73 | $46,138 |
| Xtampza ErOxycodone Myristate | 40 | $28,098 |
| NucyntaTapentadol Hcl | 13 | $22,921 |
| Fentanyl | 72 | $9,390 |
| Oxycodone Hcl | 400 | $8,352 |
| Morphine Sulfate ErMorphine Sulfate | 160 | $5,077 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 210 | $4,153 |
| Lidocaine | 20 | $2,533 |
| Gabapentin | 105 | $2,415 |
| Methadone Hcl | 59 | $2,339 |
| Baclofen | 73 | $1,627 |
| Morphine Sulfate | 56 | $1,499 |
| Hydromorphone Hcl | 70 | $1,206 |
| Tramadol Hcl ErTramadol Hcl | 17 | $857 |
| Pregabalin | 57 | $830 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta | $493 | $51,01953 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Hackensack
- Asher GoldsteinHackensack$8K
- Gary PanagiotakisHackensack$7K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.